The 25th anniversary of pioneering Adult and Pediatric Patient and Family Advisory Councils – Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn:
”Last week we celebrated the 25th anniversary of our pioneering Adult and Pediatric Patient and Family Advisory Councils (PFACs). These incredibly important volunteer-led groups, comprised of past and present patients and their caregivers, provide valuable input on so many aspects of care at Dana-Farber, improving the patient/family experience for those who come after them. We honor and appreciate the steadfast commitment of PFAC members, past and present, who courageously share their personal experiences and support our mission to provide expert, compassionate and equitable care.”
Dana-Farber Cancer Institute, located in Boston, Massachusetts, is a leading institution for cancer treatment and research. It was founded by Sidney Farber on 1947. Currently, the Institute has over 5,000 staff, faculty, and clinicians on board. They manage in excess of 640,000 outpatient visits each year, oversee more than 1,000 hospital discharges annually, and are actively involved in over 1,100 ongoing clinical trials.
As of 2023, Dana-Farber is ranked as the #4 cancer hospital globally. Dana-Farber’s research contributions include the development of Gleevec, a highly successful treatment for chronic myeloid leukemia.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023